Dihydroquinazolinone compound or pharmacologically acceptable salt, and cell growth inhibitor
US11566017B2 · kind B2 · utility
0Cited by
0References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 26, 2018 |
| Grant date | Jan 31, 2023 |
| Priority date | — |
| Expiry date | Dec 26, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a cell proliferation inhibitor comprising a compound of the formula (1) or a pharmacologically acceptable salt thereof:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.